US013 — Stockbridge, Georgia

US013 is a clinical research site located in Stockbridge, Georgia, United States 30281.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

US013 has participated in 2 clinical trials.

Therapeutic areas: Influenza, Human.

Sponsors: Novavax.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US013?

US013 has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US013 conducted?

US013 has 2 clinical trials on record. Their work covers Influenza, Human.

Is US013 accredited by Crixeo Health?

US013 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US013?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.